the value and potential of this company. It's taken a long time coming.
Only DMD exon 51 is becoming recognized for its value, which should be around $1 bn a year in sales.
Add other exons, multibillions per year.
Add antimicrobials, multibillions per year for flu alone, not to mention drug resistant TB, MRSA, MERS, antibioweapons like ebola, marburg, anthrax.
Really good patent protection.
Its a ridiculous sounding list but it is coldly logical. .
When psychological denial breaks down and people become aware of something they were unable to see for psychological reasons, it is something to behold.
That process of this denial cracking is only just in its infancy with SRPT's real value.
Sentiment: Strong Buy
paris,ruby;s claims about the patent situation is disturbing.....your opinion is?
yeah ruby, you were a doubting tom for awhile, but usagary never lost his conviction, hat's off to gary!
...but what about the patent issues you mentioned in prior posts?
just another shorty trying to cause hate & discontent